share_log

君聖泰醫藥-B：董事名單及其角色與職能

HIGHTIDE-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

Hong Kong Stock Exchange ·  Feb 2 16:42
Summary by Futu AI
君圣泰医药-B（股份代號：2511）於2024年2月2日公布了其董事會成員名單及各自的角色與職能。董事會由執行董事劉利平博士擔任主席兼行政總裁，以及于萌女士等人組成。非執行董事包括朱迅博士、馬立雄先生和江峰先生。獨立非執行董事則有譚擘先生、李靖博士和孔德偉先生。公司設有三個委員會，分別為審核委員會、薪酬委員會和提名委員會，其中譚擘先生為審核委員會主席，李靖博士在審核和薪酬委員會中擔任主席，並且是提名委員會的成員。孔德偉先生則是審核委員會和提名委員會的成員。
君圣泰医药-B（股份代號：2511）於2024年2月2日公布了其董事會成員名單及各自的角色與職能。董事會由執行董事劉利平博士擔任主席兼行政總裁，以及于萌女士等人組成。非執行董事包括朱迅博士、馬立雄先生和江峰先生。獨立非執行董事則有譚擘先生、李靖博士和孔德偉先生。公司設有三個委員會，分別為審核委員會、薪酬委員會和提名委員會，其中譚擘先生為審核委員會主席，李靖博士在審核和薪酬委員會中擔任主席，並且是提名委員會的成員。孔德偉先生則是審核委員會和提名委員會的成員。
Jun Shing Tai Pharmaceutical-B (Stock Code: 2511) announced on 2 February 2024 its list of Board members and their respective roles and functions. The Board of Directors is composed of Dr. Liu Liping, Executive Director, as Chairman and Chief Executive Officer, and Ms. Yu Meng. Non-executive directors include Dr. Chu Xun, Mr. Ma Li-Hung and Mr. Jiang Feng. The independent non-executive directors are Mr. Tan Yin, Dr. Li Jing and Mr. Kung Te-wei. THE COMPANY HAS THREE COMMITTEES, NAMELY THE AUDIT COMMITTEE, THE REMUNERATION COMMITTEE AND THE NOMINATING COMMITTEE, OF WHICH MR. TAN YIN IS THE CHAIRMAN OF THE AUDIT COMMITTEE, DR. LI CHING SERVES AS CHAIRMAN OF THE AUDIT AND REMUNERATION COMMITTEE, AND IS A MEMBER OF THE NOMINATING COMMITTEE. Mr. Kung De Wai is a member of the Audit Committee and the Nomination Committee.
Jun Shing Tai Pharmaceutical-B (Stock Code: 2511) announced on 2 February 2024 its list of Board members and their respective roles and functions. The Board of Directors is composed of Dr. Liu Liping, Executive Director, as Chairman and Chief Executive Officer, and Ms. Yu Meng. Non-executive directors include Dr. Chu Xun, Mr. Ma Li-Hung and Mr. Jiang Feng. The independent non-executive directors are Mr. Tan Yin, Dr. Li Jing and Mr. Kung Te-wei. THE COMPANY HAS THREE COMMITTEES, NAMELY THE AUDIT COMMITTEE, THE REMUNERATION COMMITTEE AND THE NOMINATING COMMITTEE, OF WHICH MR. TAN YIN IS THE CHAIRMAN OF THE AUDIT COMMITTEE, DR. LI CHING SERVES AS CHAIRMAN OF THE AUDIT AND REMUNERATION COMMITTEE, AND IS A MEMBER OF THE NOMINATING COMMITTEE. Mr. Kung De Wai is a member of the Audit Committee and the Nomination Committee.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.